(Q37176381)

18 August 2017

1 reference

title

Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring (English)

1 reference

18 August 2017

0 references

0 references

0 references

1 reference

Patrick Garnero

1

1 reference

18 August 2017

publication date

1 January 2008

1 reference

Molecular Diagnosis and Therapy

18 August 2017

published in

1 reference

18 August 2017

volume

12

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

157-170

1 reference

Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

A urine midmolecule osteocalcin assay shows higher discriminatory power than a serum midmolecule osteocalcin assay during short-term alendronate treatment of osteoporotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Prediction of bone loss using biochemical markers of bone turnover.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Intracellular machinery for matrix degradation in bone-resorbing osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Serum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

The Wnt signaling pathway and bone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

The role of collagen in bone strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Effects of PTH and alendronate on type I collagen isomerization in postmenopausal women with osteoporosis: the PaTH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Endocrine regulation of energy metabolism by the skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Preanalytical variability of biochemical markers of bone turnover.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Role of gastrointestinal hormones in postprandial reduction of bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Markers of bone turnover for the prediction of fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Risk factors for hip fracture in women with high BMD: EPIDOS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Identification of osteopenic women at high risk of fracture: the OFELY study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate: review of statistical analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

A cross-sectional study of bone turnover markers in healthy premenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Establishing a reference range for bone turnover markers in young, healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Does follow-up of osteoporotic women treated with antiresorptive therapies improve effectiveness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256280

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

21 January 2018

1 reference

12 December 2020

Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae

1 reference

12 December 2020

Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) region

1 reference

12 December 2020

The collagenolytic activity of cathepsin K is unique among mammalian proteinases

1 reference

12 December 2020

Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion

1 reference

12 December 2020

Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer.

1 reference

12 December 2020

Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease.

1 reference

12 December 2020

Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density

1 reference

12 December 2020

Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis

1 reference

12 December 2020

Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study

1 reference

12 December 2020

Biochemical markers of bone metabolism and prediction of fracture in elderly women.

1 reference

12 December 2020

Biochemical indices of bone turnover and the assessment of fracture probability

1 reference

12 December 2020

Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis

1 reference

12 December 2020

Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy

1 reference

12 December 2020

Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study

1 reference

12 December 2020

Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study

1 reference

12 December 2020

Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies

1 reference

12 December 2020

Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone

1 reference

12 December 2020

Soluble cathepsin K: a novel marker for the prediction of nontraumatic fractures?

1 reference

12 December 2020

1 reference

12 December 2020

The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation

1 reference

12 December 2020

Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis

1 reference

12 December 2020

Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption

1 reference

12 December 2020

Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease.

1 reference

12 December 2020

The usefulness of bone turnover in predicting the response to transdermal estrogen therapy in postmenopausal osteoporosis

1 reference

12 December 2020

Predictive Value of BMD for Hip and Other Fractures

1 reference

12 December 2020

Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study

1 reference

12 December 2020

Increased Dickkopf-1 expression in breast cancer bone metastases

1 reference

12 December 2020

Effect of Monitoring Bone Turnover Markers on Persistence with Risedronate Treatment of Postmenopausal Osteoporosis

1 reference

12 December 2020

Dickkopf-1 is a master regulator of joint remodeling

1 reference

12 December 2020

TRACP Influences Th1 pathways by affecting dendritic cell function

1 reference

12 December 2020

Alpha CTX as a biomarker of skeletal invasion of breast cancer: immunolocalization and the load dependency of urinary excretion

1 reference

12 December 2020

Bone turnover and the response to alendronate treatment in postmenopausal osteoporosis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03256280

1 reference

18 August 2017

1 reference